Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial

Yazar: Patrick Arnaud-Coffin, Mehdi Brahmi, Hélène Vanacker, Lauriane Eberst, Olivier Tredan, Valery Attignon, Daniel Pissaloux, Emilie Sohier, Philippe Cassier, Gwenaelle Garin, David Pérol, Jean-Yves Blay, Armelle Dufresne
Baskı/Yayın Bilgisi 2020-12-01

Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer

Yazar: Flora Nguyen Van Long, Audrey Lardy-Cleaud, Dimitri Carène, Caroline Rossoni, Frédéric Catez, Paul Rollet, Nathalie Pion, Déborah Monchiet, Agathe Dolbeau, Marjorie Martin, Valentin Simioni, Susan Bray, Doris Le Beherec, Fernanda Mosele, Ibrahim Bouakka, Amélie Colombe-Vermorel, Laetitia Odeyer, Alexandra Diot, Lee B. Jordan, Alastair M. Thompson, Françoise Jamen, Thierry Dubois, Sylvie Chabaud, Stefan Michiels, Isabelle Treilleux, Jean-Christophe Bourdon, David Pérol, Alain Puisieux, Fabrice André, Jean-Jacques Diaz, Virginie Marcel
Baskı/Yayın Bilgisi 2022-05-01